![](/img/cover-not-exists.png)
Combination chemotherapy with Zyflamend reduced the acquired resistance of bladder cancer cells to cisplatin through inhibiting NFκB signaling pathway
Xue, Yanshi, Yang, Lin, Li, Junzun, Yan, Yilin, Jiang, Qinghui, Shen, Lan, Yang, Shuai, Shen, Bing, Huang, Ruimin, Yan, Jun, Guo, HongqianVolume:
Volume 11
Language:
english
Journal:
OncoTargets and Therapy
DOI:
10.2147/OTT.S162255
Date:
July, 2018
File:
PDF, 10.36 MB
english, 2018